EcoDrugPlus

Ribosomal Protein L13

Ensembl ID : ENSCPOG00000027348
Gene Symbol: RPL13
4 Cross references
227 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSCPOG00000030681
Gene Symbol: RPL14
2 Cross references
246 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSCPOG00000015205
Gene Symbol: RPL18A
4 Cross references
317 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCPOG00000022530
Gene Symbol: RPL19
4 Cross references
243 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCPOG00000020139
Gene Symbol: RPL22
4 Cross references
230 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSCPOG00000010002
Gene Symbol: RPL23
2 Cross references
214 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSCPOG00000031851
Gene Symbol: RPL26
2 Cross references
230 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSCPOG00000012833
Gene Symbol: RPL28
3 Cross references
210 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSCPOG00000011738
Gene Symbol: RPL29
2 Cross references
276 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSCPOG00000010038
Gene Symbol: RPL3
2 Cross references
283 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSCPOG00000030315
Gene Symbol: RPL30
2 Cross references
254 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSCPOG00000019967
Gene Symbol: RPL32
2 Cross references
80 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).